Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones
- PMID: 9303412
- PMCID: PMC164063
- DOI: 10.1128/AAC.41.9.2037
Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones
Abstract
The in vitro activities of six antimicrobial agents were tested against 162 mycoplasma strains of eight species isolated from poultry and livestock at different geographic sites. Tiamulin was most active (MICs at which 90% of the isolates were inhibited [MIC90s], 0.025 to 0.25 microg/ml); enrofloxacin and danofloxacin had near equivalent activities (MIC90s, 0.05 to 1.0 microg/ml), but were much more active than flumequine (MIC90s, 1 to 50 microg/ml). The MIC90s of tylosin and oxytetracycline were 0.25 to > 100 microg/ml and 0.25 to 100 microg/ml, respectively.
Similar articles
-
In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance.Res Vet Sci. 1993 May;54(3):329-34. doi: 10.1016/0034-5288(93)90130-8. Res Vet Sci. 1993. PMID: 8393208
-
In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.Avian Dis. 2001 Apr-Jun;45(2):456-60. Avian Dis. 2001. PMID: 11417828
-
In vitro susceptibilities of field isolates of Mycoplasma agalactiae to oxytetracycline, tylosin, enrofloxacin, spiramycin and lincomycin-spectinomycin.Res Vet Sci. 2003 Aug;75(1):3-7. doi: 10.1016/s0034-5288(03)00030-4. Res Vet Sci. 2003. PMID: 12801456
-
In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae.Res Vet Sci. 1997 Sep-Oct;63(2):157-60. doi: 10.1016/s0034-5288(97)90010-2. Res Vet Sci. 1997. PMID: 9429250
-
Enrofloxacin: a new antimicrobial agent.J S Afr Vet Assoc. 1989 Jun;60(2):122-4. J S Afr Vet Assoc. 1989. PMID: 2691696 Review.
Cited by
-
Antimicrobial Resistance in Mycoplasma spp.Microbiol Spectr. 2018 Jul;6(4):10.1128/microbiolspec.arba-0030-2018. doi: 10.1128/microbiolspec.ARBA-0030-2018. Microbiol Spectr. 2018. PMID: 30003864 Free PMC article. Review.
-
Antimicrobial susceptibility profiles of Mycoplasma hyosynoviae strains isolated from five European countries between 2018 and 2023.Sci Rep. 2025 Jan 7;15(1):1243. doi: 10.1038/s41598-024-85052-1. Sci Rep. 2025. PMID: 39774192 Free PMC article.
-
Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene.Antimicrob Agents Chemother. 2006 Jun;50(6):1959-66. doi: 10.1128/AAC.01527-05. Antimicrob Agents Chemother. 2006. PMID: 16723552 Free PMC article.
-
Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method.PLoS One. 2018 Dec 11;13(12):e0209030. doi: 10.1371/journal.pone.0209030. eCollection 2018. PLoS One. 2018. PMID: 30533041 Free PMC article.
-
Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum.Front Vet Sci. 2016 Sep 6;3:75. doi: 10.3389/fvets.2016.00075. eCollection 2016. Front Vet Sci. 2016. PMID: 27656647 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources